A second class action lawsuit was filed against manufacturers and distributors of a high blood pressure drug that was found to be contaminated with a probable cancer-causing impurity. The lawsuit was filed in Boston federal court against New Jersey-based Camber Pharmaceuticals Inc., and Hetero Drugs Ltd. Hetero is based in India but makes the drug ingredient, valsartan, with its partner, Hetero USA Inc., also based in New Jersey. The lawsuit claims poor safety procedures at the India plant should have tipped the companies off years ago that the drugs could be contaminated. Instead, the companies “willfully ignored warning signs.” In ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.